- Which applications qualify for the Continuous Submission program?
- Who is eligible for Continuous Submission?
- Does this opportunity apply to new applications only?
- How are applications with multiple Program Directors/Principal Investigators (PDs/PIs) handled?
- What is the last date I can submit my continuous submission application and have it reviewed in a standing study section?
- I’m eligible for Continuous Submission. Am I also eligible for the two-week late window of consideration for submitting after the deadline?
Continuous Submission only applies to R01, R21, and R34 applications; applications using other mechanisms (e.g. R03, or R15) are NOT eligible for Continuous Submission. The application must be submitted under an FOA (Funding Opportunity Announcement) that uses Standard Due Dates. Since RFA FOAs do not use Standard Due Dates, applications in response to an RFA are not eligible for Continuous Submission. At least one of the PD/PIs on the application must be eligible for Continuous Submission at the time of submission.
Applications submitted under the continuous submission option must include a cover letter that states the eligibility of a PD/PI for continuous submission and follow the Schedule For Assignment to Advisory Council Rounds Under Continuous Submission Option (see NOT-OD-17-042 and NOT-OD-18-178).
Appointed members of standing NIH study sections, NIH Boards of Scientific Counselors, NIH Advisory Boards or Councils, or NIH Program Advisory Committees are all eligible for Continuous Submission. Reviewers who have served on at least 6 qualifying NIH study sections during an 18-month period starting January 1 of one year and ending June 30 of the following year are also eligible for Continuous Submission under the Recent Substantial Service option.
No, Continuous Submission applies to new applications, resubmissions (A1), competing renewals (type 2), and revisions (type 3) for R01, R21, and R34 activity codes submitted to an FOA (Funding Opportunity Announcement) that uses Standard Due Dates.
If an application has Multiple PD/PIs, and any of the PD/PIs is eligible for continuous submission, the application is eligible for continuous submission. Note: having a co-investigator or collaborator who is eligible for continuous submission does not make the application eligible for continuous submission; the eligible reviewer must be in a PD/PI position on the application.
According to the current NIH policy (NOT-OD-17-042 and NOT-OD-18-178), continuous submission-eligible applications may be reviewed in a standing study section if an appropriate study section is not in conflict with the application, at the IRG/Review Chief’s discretion. However, the closer the submission date is to the Advisory Council-dictated deadlines (below in #19), the more likely it becomes that the application will need to be assigned to a Special Emphasis Panel in order to be reviewed in a timely manner.
Continuous submission-eligible PD/PIs who want to submit applications that are not eligible for Continuous Submission (NOT standard due date, or NOT: R01, R21, or R34) must submit within the two week late window of consideration per the late policy (NOT-OD-15-039).
Yes. If you are eligible for Continuous Submission, you are also eligible for the two-week Late Window of Consideration after the application due date even if you haven’t reviewed within two months of the due date (See NOT-OD-15-039 for more information about the Late Window of Consideration). You must include a cover letter stating that, while your application is late, you qualify for Continuous Submission and are requesting that your application still be accepted. For this, your application must be successfully submitted within two weeks of the Due Date. A late window cannot be used to extend the Application Receipt Periods for assignment to Advisory Council rounds. Note: the Late Window of Consideration applies to all FOAs (Funding Opportunity Announcements), unless the FOA specifically states that late applications will not be accepted.